Diseases, Conditions, Syndromes

FDA approves first RSV vaccine

The first vaccine for respiratory syncytial virus (RSV) has been approved by the U.S. Food and Drug Administration for use in seniors aged 60 and older.

Neuroscience

US FDA approves nasal spray for migraines

The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said Friday.

Medications

Paxlovid soon will not be free for Americans

The antiviral Paxlovid has kept patients from becoming severely ill and dying from COVID-19 since it became available—at no cost to them. But by the middle of next year, the U.S. government will stop subsidizing the medication. ...

Cardiology

Which COVID vaccine you get could affect your myocarditis risk

Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases ...

Vaccination

4.4M Americans roll up sleeves for omicron-targeted boosters

U.S. health officials say 4.4 million Americans have rolled up their sleeves for the updated COVID-19 booster shot. The Centers for Disease Control and Prevention posted the count Thursday as public health experts bemoaned ...

page 4 from 40